To obtain documents, log on:
:
Not registered? Register me now
 

Public Higher Education Bulletin

 
University of Illinois at Chicago
Exemption #JMG609

Announcement of an Exempt Purchase

Change Order
Published Wednesday June 30, 2021
Vendor: Biogen Direct
Change Order Amount: $0
Please note: Biogen Direct, LLC payments are made via AmerisourceBergen Drug Corporation.

The Chief Procurement Officer for this procurement is now John Donato.
The University award process may be delayed up to thirty days as this award goes through a state approval process.

Award Info Published Friday February 1, 2019

Biogen DirectFrisco, TX

  • Amount: An estimated $4,500,000
  • Terms: An estimated start date of 2/1/2019 through 6/30/2022
  • Renewals: None

The University award process may be delayed up to thirty days as this award goes through a state approval process.

First published Friday, February 1, 2019
The University awarded a contract for Tecfidera (dimethyl fumarate).
Tecfidera (dimethyl fumarate) is an oral medication used to treat relapse-remitting multiple sclerosis (RRMS).
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical services necessary for the delivery of care and treatment at medical, dental, or veterinary teaching facilities utilized by SIU or U of I (30 ILCS 500 / 1-13(b-5)) Biogen Direct is the exclusive distributor and without the purchase of Tecfidera, patient care and revenue could be compromised.

For instructions on how to obtain a comprehensive purchase description, disclosure or contract forms, contact:
Janielle Graham
809 S. Marshfield Ave.
3rd Floor
Chicago, IL 60612
Phone: (312) 413-2816
FAX: (312) 996-3135

The State of Illinois has a policy to encourage prospective vendors to hire qualified veterans, minorities, females, persons with disabilities and ex-offenders.

Bulletin Navigation

 
To obtain documents, log on:
Exemption Document
  • ExemptionJMG609Biogen.pdf (127 KB)